Global Cannabis Regulatory Summit: A Milestone for International Collaboration and Growth

Inaugural Global Cannabis Regulatory Summit Set for Washington D.C.

Artemis Growth Partners, a globally focused investment firm, in collaboration with Tenacious Labs, is preparing for the inaugural Global Cannabis Regulatory Summit (GCRS). Set to take place from March 25-27, 2025, in Washington D.C., this groundbreaking event will gather Congress members, international regulators, and industry experts to carve pathways for a cohesive, global cannabis economy.

This summit promises to be a landmark gathering, offering a rare opportunity for attendees, including industry leaders and regulators, to engage in meaningful discussions on the future of cannabis legislation worldwide. Taking place at the U.S. Capitol Complex, the summit will feature a reception for guests in Georgetown on the evening of March 25, followed by a full agenda of panels and networking opportunities.

Summit Highlights

The GCRS will focus on the convergence of regulators and cannabis industry executives from around the globe. As global cannabis sales in regulated markets are projected to exceed USD $51 billion this year, the summit aims to address the urgent need for intercontinental collaboration in cannabis legislation and market development.

Key sponsors, including AON, Aurora, and Curaleaf, alongside consultancy groups and industry organizations, are providing substantial backing and expertise for the summit. The carefully curated attendee list aims to stimulate interaction among legislators, international policy experts, and cannabis executives, creating a platform for discussions that could influence both emergent and established markets.

Addressing Global Trends

The summit comes at a pivotal time as the U.S. is engaging in rescheduling cannabis, while various countries in Europe and beyond are establishing their legal frameworks. Participants at GCRS will have the opportunity to share and exchange ideas on accelerating the momentum for legalization in different jurisdictions, emphasizing its potential for global development.

Regulator Focus

For invited regulators, the GCRS presents an invaluable chance to network and learn in a specialized setting that fosters relationships that could impact their home jurisdictions. By engaging with peers and experts, regulators can gain insights that help shape effective and sensible policies tailored to cannabis legalization.

Public Attendance

The summit also opens its doors to general audience attendees, offering an intimate environment where they can network with decision-makers and learn from the experiences of regulators. Attendees will be privy to panel discussions and presentations focused on medical cannabis as well as adult-use markets, supplemented by networking dinners and social events.

Looking Ahead

The first day of programs, starting on March 26, will include various panel discussions diving into pivotal topics within the medical cannabis market. A second day, focused on the adult-use segment, will further explore themes such as 'Cannabis in the Americas' and 'Moving from Prohibition to Regulation in Europe'.

Will Muecke, co-founder and chief investment officer of Artemis Growth Partners, expressed enthusiasm about the event, stating, "We are thrilled to provide a necessary space for regulators and experts to discuss the outlook for the global cannabis market. As legislation evolves, the importance of an interconnected supply chain not only for products but also for capital has become critical for sustainable growth."

The GCRS aims to become an annual must-attend event for cannabis regulators, industry leaders, and investors moving forward. The insights gained could shape future legislation and foster long-term connections crucial for the global cannabis landscape.

For further information about sponsorship or attendance, please visit https://cannabisregsummit.com/.

About Artemis Growth Partners

Founded in 2017, Artemis Growth Partners specializes in impact investing within the cannabis sector, with a strong commitment to ESG principles. Their diverse portfolio includes 39 companies across the Americas and Europe, aiming to lead in sustainable and ethical cannabis practices.

About Tenacious Labs

Tenacious Labs is dedicated to ensuring high-quality cannabinoid products and effective regulation through scientific rigor and consumer-focused values. Headquartered in London with branches in Miami and Colorado, they are committed to innovation and sustainability within the cannabinoid market.